Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review.

Vaishnav J, Bampatsias D, Boursiquot BC, Brailovsky Y, Hsu K, Zigterman J, Chakraborty R, Wechalekar A, Pavia PG, Witteles R, Hanna M, Karam C, Maurer MS, Griffin JM

Open source

DOI
10.1016/j.jaccao.2026.02.004
Published
2026 Apr
Container
JACC. CardioOncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaccao.2026.02.004,
  title = {Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review.},
  author = {Vaishnav J and Bampatsias D and Boursiquot BC and Brailovsky Y and Hsu K and Zigterman J and Chakraborty R and Wechalekar A and Pavia PG and Witteles R and Hanna M and Karam C and Maurer MS and Griffin JM},
  year = {2026},
  journal = {JACC. CardioOncology},
  doi = {10.1016/j.jaccao.2026.02.004},
  url = {https://doi.org/10.1016/j.jaccao.2026.02.004}
}

RIS

TY  - JOUR
TI  - Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review.
AU  - Vaishnav J
AU  - Bampatsias D
AU  - Boursiquot BC
AU  - Brailovsky Y
AU  - Hsu K
AU  - Zigterman J
AU  - Chakraborty R
AU  - Wechalekar A
AU  - Pavia PG
AU  - Witteles R
AU  - Hanna M
AU  - Karam C
AU  - Maurer MS
AU  - Griffin JM
PY  - 2026
JO  - JACC. CardioOncology
DO  - 10.1016/j.jaccao.2026.02.004
UR  - https://doi.org/10.1016/j.jaccao.2026.02.004
ER  - 

APA

J, V., D, B., BC, B., Y, B., K, H., J, Z., R, C., A, W., PG, P., R, W., M, H., C, K., MS, M., & JM, G. (2026). Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review.. JACC. CardioOncology. https://doi.org/10.1016/j.jaccao.2026.02.004

Source records